Neurally adjusted ventilatory assist (NAVA) is a mode of mechanical ventilation in which inspiratory pressures are proportional to the electrical activity of the diaphragm (EAdi). 1 2 Ventilator support is initiated by detecting the diaphragmatic neural drive and is cycled off with termination of respiratory output by the respiratory centres. 3 4 Recent studies demonstrate that NAVA may have a beneficial effect compared with standard pressure-support ventilation (PSV), by reducing asynchrony in intubated and spontaneously breathing intensive care patients 5 6 and improving oxygenation of critically ill postoperative patients. 7 By measuring and presenting EAdi at each cycle as a waveform, the NAVA mode also allows continuous bedside monitoring of neural respiratory drive to the diaphragm. Assuming that EAdi represents temporal and spatial summation of neural impulses, which are translated into diaphragm muscle fibre action potentials, its amplitude relates to changes in motor-unit firing rate and recruitment.
of NVE could also be useful to manage weaning from mechanical ventilation, as the patient's load or muscular function improves. 10 11 To our knowledge, no previous study has investigated the course of NVE monitoring during weaning off mechanical ventilation under NAVA. We tested the hypothesis that in patients in whom NAVA has been used to wean off prolonged mechanical ventilation for severe acute hypoxaemic respiratory failure, NVE may be significantly improved, and changed from failed to successful spontaneous breathing (SBT).
Methods

Study population
This observational study was approved by our institutional review board (Comité de Protection des Personnes Sud-Ouest et Outre Mer III, Bordeaux, France) and was conducted in our 10-bed thoracic critical care unit. Informed consent from all patients was obtained. Patients who had been mechanically ventilated for .4 consecutive days, and who were being weaned off mechanical ventilation using the NAVA mode, were included in this study.
Ventilatory management
Patients' lungs were ventilated using a Servo-I ventilator with NAVA (Maquet Criticial Care, Solna, Sweden). A heated humidifier was used for gas conditioning. EAdi was obtained through a nasogastric tube with a multiple array of electrodes placed at its distal end (EAdi catheter, Maquet Critical Care). 2 12 Correct positioning of the EAdi catheter was ensured using a specific function of the ventilator ('EAdi catheter positioning'). 13 As previously described by our group, 14 patients were initially switched from volume-cycled ventilation to PSV for 1 h. The fixed level of pressure support was adapted to obtain a V T of 7 ml kg 21 of ideal body weight. Subsequently, a 2 h SBT was performed using PSV with 7 cm H 2 O of pressure support without PEEP.
Failing an SBT was defined as developing hypoxaemia (S p O 2 ,88% for ≥5 min), abrupt changes in mental status, an acute cardiac arrhythmia, or two or more signs of respiratory distress, including tachycardia (.130 beats min 21 ), bradycardia (,50 beats min 21 ), use of accessory muscles, abdominal paradox, diaphoresis, or marked dyspnoea. If SBT was well tolerated for at least 2 h, patients were considered weaned from mechanical ventilation and extubation was discussed, otherwise NAVA was used. In the latter case, NAVA level was titrated in order to obtain EAdi values of 60% of the highest EAdi measured during SBT (EAdi maxSBT ). According to our protocol, the use of NAVA was called NAVA 60% SBT . Each EAdi was recorded with its corresponding V T . The V T to EAdi ratio that represented NVE was recorded during NAVA and during SBT. Modification of NAVA level was done at least once a day after unsuccessful SBT; thus, NAVA level was titrated the day before successful SBT. Data were collected on the Servo-I using a specific PCMCIA card (Maquet Criticial Care). The card recorded each respiratory parameter and gave the mean respiratory frequency per minute, V T , airway pressure, and peak electrical diaphragm activity. Screen copies of Servo-I were also saved on the card.
Data obtained during the last minute of unsuccessful or successful SBTs were reported. The primary endpoint was the comparison of NVE during NAVA 60% SBT and SBT in two different clinical situations, that is, on the day of the first unsuccessful SBT and also on the day of successful SBT. 
Statistical analyses
Data are expressed as mean (SD) for normally distributed continuous variables, median [inter-quartile range (IQR)] for nonnormally distributed continuous variables, and number (% of patients) for categorical data. The normal distribution of continuous variable was assessed using skewness and kurtosis tests. A paired Student's t-test and Wilcoxon's matchedpair signed-rank tests were used to compare means and medians, respectively. All P-values were two-tailed and a P-value of ,0.05 was required to reject the null hypothesis. Statistical analyses were performed with the NCSS software (Statistical Solutions Ltd, Cork, Ireland).
Results
Between February and September 2011, 12 patients who had presented with severe acute respiratory failure and could be weaned off mechanical ventilation using a NAVA ventilator were included. The patients' characteristics are summarized in Table 1 . Nine of the 12 patients were men. The median time between unsuccessful and successful SBT was 5 days (range: 3 -7).
Between the beginning and end of weaning, while patients were under NAVA, NVE decreased significantly (Table 2, Fig. 1A ). EAdi increased significantly, whereas V T remained unchanged (Table 2) . Simultaneously, the level of pressure assist decreased significantly (Table 2) . Moreover, on the day of successful SBT, the level of pressure assist under NAVA 60% SBT was significantly .7 cm H 2 O (P¼0.01). PEEP under NAVA was no different between unsuccessful and successful SBTs [5.5 (1.6) vs 5 (2) cm H 2 O, P¼0.13].
Between the start and end of the weaning period, when the patients were under SBT, NVE remained unchanged (Fig. 1B) , whereas V T and EAdi increased significantly ( Table 2) .
The switch from NAVA 60% SBT to SBT was associated with significant decreases in NVEs at the beginning and end of weaning ( Table 2 , Fig. 1 ). However, this decrease was smaller when SBT was successful [256 (8)% vs 238 (17)%, P¼0.001; Fig. 2] . No change in V T , respiratory rhythm (RR) and RR/V T occurred between NAVA 60% SBT and SBT in patients who passed their SBT, whereas a discrepancy occurs during failed SBT (Table 2, Fig. 2) .
During SBT, patients failed the test within 10 min. This was associated with marked dyspnoea, high respiratory rate, and low V T in all patients, except for two patients (Nos 1 and 7) who developed severe hypoxaemia with Sp O 2 ,88%.
Discussion
The major findings from our study of patients who required prolonged mechanical ventilation after severe, acute respiratory failure include: (i) during failed SBT, the switch from NAVA 60% SBT to SBT was associated with decreased NVE because of removal of the NAVA pressure assist. When SBT was successful, NVE also decreased, but the variation in the index was significantly reduced, and V T remained the same; and (ii) there was no difference in NVE during unsuccessful and successful SBTs although EAdi and V T increased significantly. Variations in NVE between NAVA 60% SBT and daily reproducible inspiratory effort (SBT) seemed to be associated with the patient's progress as they were weaned off mechanical ventilation.
The range of NVE values for the 12 patients was large. EAdi was probably affected by inter-individual anatomical differences, such as an increased distance between the electrodes in the oesophagus and/or because the crural diaphragm lowers the amplitude of EAdi. 15 However, during unsuccessful SBT, NVE was lower, as described in other recent studies. 10 11 NVE during SBT, between the beginning and end of the weaning process, was associated with significantly increased V T and EAdi. Thus, the ratio of V T /EAdi during SBT did not differ between the beginning and end of the weaning process (Fig. 3B) .
NVE reflects the volume-generated determinants, which are respiratory drive, diaphragm function, and respiratory load. These determinants may explain why patients increase their EAdi and V T during the same load (PSV 7 cm H 2 O). The increase in EAdi max during SBT during the weaning process has been already described.
14 This may be because respiratory drive is inhibited by the presence of residual sedative drugs, still present at the beginning of the weaning process. Indeed, in the present study, patients had .4 days of controlled mechanical ventilation with sedation to inhibit the respiratory drive. A progressive significant increase in V T and EAdi from first failed to successful SBT may suggest an increased degree of wakefulness. NVE under NAVA decreased between the beginning and end of the weaning process. This was associated with the daily reduction in NAVA level and pressure assist according to our NAVA protocol. NAVA level reduction was associated with lower pressure assist but similar V T resulting in a well tolerated increase in the patient's breath contribution and EAdi. Thus, decreased NVE was associated with the patient's recovery and did not mean that patient's efficiency has worsened.
In the present study, PEEP was removed during SBT, which can change NVE significantly. 9 However, the difference in pressure between unsuccessful and successful SBT was essentially the level of pressure assist above PEEP, as PEEP remained the same under NAVA. V T and RR/V T variations between NAVA and SBT could also help distinguish successful SBT as no change in V T , RR, and RR/V T occurred between NAVA 60% SBT and SBT in patients who have passed their SBT, whereas a discrepancy in V T and RR/V T was significant during failed SBT.
Many studies have assessed the possibility of reliably predicting weaning in critically ill patients, such as the ratio of respiratory frequency over expired V T . 16 However, this index, like others, is a poor predictor of weaning outcome. 17 18 The NVE index could help distinguish extubation failure and weaning failure during NAVA; 10 11 however, such studies need a large number of patients, as the prevalence of extubation failure is low. It is important to think about the following points when considering the clinical relevance of our study. Here, NVE was studied during the weaning process and in a specific category of patients after severe acute hypoxaemic respiratory failure and prolonged controlled ventilation and sedation. It stands to reason that these results may be different in other clinical situations of respiratory failure. Moreover, two patients had bipulmonary lung transplantations, which changed their control over breathing, as vagal reflexes were absent. In addition, this was an observational study, with only 12 patients enrolled; therefore, it was not possible to do inter-individual comparisons. For each patient, we were only able to compare NVE on two occasions, on the day of the first unsuccessful SBT and on the day of successful SBT; which enabled us to compare these sets of data, but not to monitor theirevolutionary change. Lastly, NVE was not accurately analysed cycle-by-cycle with specific software. We used the EAdi pic and V T data provided by the Servo-I on screen to enable measurements to be made at the clinical bedside. Consequently, a possible delay between EAdi and V T cannot be ruled out. The data in our study indicate that EAdi can be used as a valuable bedside monitoring tool and provide clinicians with relevant information on a patient's respiratory status during mechanical ventilation. The variations in V T and NVE, seen between NAVA and a reproducible inspiratory effort (daily SBT), were associated with a patient's recovery from severe acute hypoxaemic respiratory failure and prolonged mechanical ventilation. Furthermore, NVE was no different during unsuccessful and successful SBTs but associated with a significant increase in both V T and EAdi. Further clinical trials, incorporating larger cohorts and including patients with other respiratory conditions, are necessary to elucidate whether NVE differences or variations can provide enough information to diagnose patient recovery and to reliably predict weaning in critically ill patients.
